Logo trang chủ
  • Giới thiệu
  • Bảng giá
  • Hướng dẫn sử dụng
  • Văn bản
  • Tin tức
  • Chính sách
  • Biểu mẫu
  • Trang cá nhân
Logo trang chủ
  • Trang chủ
  • Văn bản
  • Pháp luật
  • Bảng giá
Trang chủ » Văn bản » Y tế

Thông tư 19/2021/TT-BYT của Bộ Y tế về việc quy định mẫu văn bản, báo cáo thực hiện Nghị định 98/2021/NĐ-CP ngày 08/11/2021 của Chính phủ về quản lý trang thiết bị y tế

Value copied successfully!
Số hiệu 19/2021/TT-BYT
Loại văn bản Thông tư
Cơ quan Bộ Y Tế
Ngày ban hành 16/11/2021
Người ký Đỗ Xuân Tuyên
Ngày hiệu lực
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.
Tình trạng
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.
  • Mục lục
  • Lưu
  • Theo dõi
  • Ghi chú
  • Góp ý

MINISTRY OF HEALTH OF VIETNAM
-------

SOCIALIST REPUBLIC OF VIETNAM
Independence - Freedom – Happiness
---------------

No. 19/2021/TT-BYT

Hanoi, November 16, 2021

 

CIRCULAR

On templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices

Pursuant to Decree No. 75/2017/ND-CP dated June 20, 2017 of the Government on functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices;

At the request of the Director of the Department of Medical Equipment and Construction,

The Minister of Health hereby promulgates a Circular on templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices.

Article 1. Scope

This Circular provides for templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices.

...

...

...

Organizations and individuals involved in activities relating to medical devices, including: classification of medical devices; production, clinical research, circulation, purchase, sale, export, import, and service provision of medical devices; advertising of medical devices; management of prices of medical devices, and management and use of medical devices at health facilities.

Article 3. Templates of documents and reports on implementation of Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices

Templates of documents and reports enclosed herewith in Appendices include:

1. Appendix I: Template of written declaration of, disclosure of, statement of, notification of or application for issuance of marketing authorization number, import license and certificate of free sale.

2. Appendix II: Personnel list template.

3. Appendix III: Template of confirmation of work period.

4. Appendix IV: Template of medical device application for declaration, certificate, import license.

5. Appendix V: Template of classification results.

6. Appendix VI: Template of letter of authorization

...

...

...

8. Appendix VIII: Template of technical document for medical devices.

9. Appendix IX: Template of report on receipt, dispatch, inventory, use of medical devices, production materials, EQA reagents that contain narcotics/precursors.

10. Appendix X: Template of written commitment and application for resumption of circulation of medical devices.

11. Appendix XI: Template of clinical research on medical devices.

Article 4. Responsibilities for implementation

Organizations and individuals involved in activities relating to medical devices are responsible for implementation of this Circular.

Article 5. Implementation provisions

1. This Circular comes into force from January 01, 2022.

2. Difficulties that arise during the implementation of this Circular should be reported to the Ministry of Health for consideration and settlement.

...

...

...

 

PP. MINISTERDEPUTY MINISTERDo Xuan Tuyen

 

APPENDIX I

Template of declaration of, disclosure of, statement of, notification of and application for issuance of number of marketing authorization, import license and certificate of free sale(enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health)

Template No. 01

Declaration of eligibility for production of medical devices

Template No. 02.01

Declaration of applied standards of class A medical devices

...

...

...

Declaration of applied standards of class B medical devices

Template No. 03.01

Application for issuance of marketing authorization numbers of class C and class D medical devices subject to national technical regulations

Template No. 03.02

Application for issuance of marketing authorization numbers of class C and class D medical devices which are measuring instruments subject to sample approval

Template No. 03.03

Application for issuance of marketing authorization numbers of class C and class D medical devices eligible for quick issuance

Template No. 03.04

Application for issuance of marketing authorization numbers of class C and class D medical devices eligible for emergency use authorization

...

...

...

Application for issuance of marketing authorization numbers of other class C and class D medical devices

Template No. 04

Declaration of eligibility for trading of medical devices

Template No. 05

Application for medical device import licence

Template No. 06

Declaration of eligibility for provision of medical device consulting services

Template No. 07

Application for certificate of free sale of the medical devices

...

...

...

Notification of updated information in application for declaration of eligibility for production of medical devices

Template No. 09

Notification of updated information in application for declaration of applied standards of class A and class B medical devices

Template No. 10

Notification of updated information in application for marketing authorization of class C and class D medical devices

Template No. 11

Notification of updated information in application for declaration of eligibility for trading of class B, class C and class D medical devices

Template No. 12

Notification of updated information in application for declaration of eligibility for provision of medical device consulting services

...

...

...

Quotation for medical devices

Template No. 13.01

Updated quotation for medical devices

Template No. 14

Disclosure of medical device advertising contents and formats

Template No. 15

Declaration of materials used for production of medical devices and EQA reagents that contain narcotics/precursors

 

APPENDIX II

...

...

...

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------…....1....., day.......month.......year 20.....

personnel list

Name of facility: …………………………………………………………………………..

Address:…………………………………………………………………………..

No.

Full name

Position

Professional qualification

Process of working in the medical device-related field

...

...

...

Work unit

Work period

Designated position

Main assigned tasks

Name of training institution

Training major

Qualifications

Training type

Training duration

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

2

 

 

 

 

 

 

...

...

...

 

 

 

 

 

3

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

Legal representative of the facility(Signature (full name, title))Confirmed by seal or digital signature 

___________________

 1Geographic name.

 

APPENDIX III

Application for cONFIRMATION of work period template(Enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health of Vietnam)

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

Application for cOnfirmation of work period

To:…………1………………..

...

...

...

Date of birth:……………………………………………….

ID/passport: ………..date of issue: ……………………. Place of issue: ........................

I would like to have the following information confirmed:

I have worked or have been working at:……………………………………….

Working period: from ……(date)…… to ……(date)..................

Designated position:…………………………………………

Main assigned tasks:……………………………………..

.............................................................................................................................

.............................................................................................................................

...

...

...

Sincerely!

 

…..2….., day… month… year 20……confirmation of EMPLOYER(signature, full name, confirmation)

 APPLICANT(signature and full name)

___________________

1Name of the employer.

2Geographic name

 

APPENDIX IV

...

...

...

Template No. 01

Template of application for declaration of eligibility for production of medical devices

Template No. 02.01

Template of application for declaration of applied standards of class A medical devices

Template No. 02.02

Template of application for declaration of applied standards of class B medical devices

Template No. 03

Certificate of marketing authorization of class c and class D medical devices

Template No. 04

...

...

...

Template No. 05

Medical device import license

Template No. 06

Template of application for declaration of eligibility for provision of medical device consulting services

Template No. 07

Certificate of free sale of medical devices

Template No. 08

Template of application for declaration of materials used for production of medical devices and EQA reagents that contain narcotics/precursors

 

...

...

...

TEmplate of medical device classification results(enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health)

FACILITY’S NAME-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No. ………..

….1…, day….month…..year 20…..

 

medical device classification results

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices;

Pursuant to Circular No. 39/2016/TT-BYT dated October 28, 2016 of the Ministry of Health elaborating classification of medical devices.

...

...

...

No.

Name of medical device

Category/ code of product

Manufacturer, country of production

Manufacturer, country of product owner

Uses according to the owner’s assignation

Grounds for risk classification

Risk level

 

...

...

...

 

 

 

 

 

 

 

 

Legal representative of classifying facility(Signature (full name, title))Confirmed by seal or signature 

...

...

...

1Geographic name

 

APPENDIX VI

LETTER OF authorization TEMPLATE(Enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health of Vietnam)

Headline (name and address) of the owner of the medical device

Day ………month…….. year 20 ....................

Letter of authorization

To: ……………………………………………………

We, (name and address of the Product Owner), as the owner of the medical devices listed hereunder, hereby authorize (name and address of the organization authorized to announce applicable standards in its name or register for circulation) to place/ register the following medical devices to the market of Vietnam:

...

...

...

We hereby commit to provide and support any inquiry related to the information and quality of the medical devices, guarantee all warranty, maintenance and service conditions and supply replacement materials and accessories for the medical devices.

This Letter of Authorization is valid until: ….. date (dd/mm/yy)

 

 

Legal representative of the ownerSignature (full name, title)Confirmed by seal or signature 

 

APPENDIX VII

Confirmation of eligibility for warranty teMPLATE(Enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health of Vietnam)

Headline (name and address) of the owner of the medical device: …………………

...

...

...

CONFIRMATION OF ELIGIBILITY FOR WARRANTY

Name: …………………………………..

Address:…………………………………………………………………………..

As the owner of the medical device, we confirm that the below-named facilities are eligible for warranty on the medical device of …..1……………

Name of medical device

Name of warranty facility

TIN

Address

Landline

...

...

...

......

Facility 1

 

 

 

 

Facility 2

 

 

...

...

...

 

......

Facility 1

 

 

 

 

Facility 2

 

...

...

...

 

 

Facility 3

 

 

 

 

......

......

...

...

...

 

 

 

 

 

Legal representative of the ownerSignature (full name, title)Confirmed by seal or signature 

___________________

1Full name of the owner of the medical device

 

...

...

...

Templates of technical documents for medical devices(enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health)

As for medical devices which are reagents, calibration substances, in vitro control materials

Template No. 01

Technical documents for reagents, calibration substances, in vitro control materials

As for chemicals and preparations serving the only purpose of disinfecting medical devices

Template No. 02

Documentation of brief technical description of chemicals and preparations serving the only purpose of disinfecting medical devices

As for medical devices which are neither reagents, calibration substances, in vitro control materials nor chemicals and preparations serving the only purpose of disinfecting medical devices

Template No. 03

...

...

...

Template No. 04

Documentation of brief technical description of imported medical devices

As for materials used for production of medical devices and EQA reagents that contain narcotics/precursors

Template No. 05

Technical documents on materials used for production of medical devices and EQA reagents that contain narcotics/precursors

 

APPENDIX IX

Template of report on receipt, dispatch, inventory, use of medical devices, production materials, EQA reagents that contain narcotics/precursors(enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health)

FACILITY’S NAME-------

...

...

...

No. ………..

 

 

REPORT ON RECEIPT, DISPATCH, INVENTORY, USE IN ............Of medical devices and EQA reagents that contain narcotics/precursors

To: ……………………………………………………

No.

Name of medical device/ production material/ EQA reagent

Number of declaration

Narcotic/ precursor

...

...

...

CAS code

Content in a smallest packing unit

Unit

Remaining quantity of the previous period

Received quantity

Used1

Dispatched quantity

Remaining quantity at the end of the current period

Loss2

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

This report is enclosed with the detailed list of names and addresses of customers, and names and quantity of narcotics/ precursors dispatched in the year.

 

…….(location), day…… month……year…….Legal representative of the facilitySignature (full name, title)Confirmed by seal or signature 

___________________

...

...

...

2Including the quantity of destroyed products and expired products, etc. If any, a detailed report is required

 

APPENDIX X

Template of written commitment and application for resumption of circulation of medical devices(enclosed with Circular No. 19/2021/TT-BYT dated November 16, 2021 of the Minister of Health)

Template No. 01

Template of applications for resumption of circulation of medical devices and written commitments to take responsibility for warranty, preservation, provision of materials for the use of medical devices

Template No. 02

Template of written consents for resumption of circulation of medical devices

 

...

...

...

Template of clinical research on medical devices

Template No. 01

Application for approval for clinical research on medical devices

Template No. 02

Description of clinical research on medical devices

Template No. 03

Certificate of approval for clinical research protocol

Template No. 04

Decision on approval for clinical research protocol on medical devices

...

...

...

Application for approval for revised clinical research protocol on medical devices

Template No. 06

Certificate of approval for revised clinical research protocol

Template No. 07

Decision on approval for revised clinical research protocol on medical devices

Template No. 08

Application for approval for results of clinical research on medical devices

Template No. 09

Report on results of clinical research on medical devices

...

...

...

Certificate of approval for results of clinical research on medical devices

Template No. 11

Decision on approval for results of clinical research on medical devices

 Template No. 01

FACILITY’S NAME-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.      /…..Re. application for approval for clinical research on medical device

Hanoi, day    month    year 20…

 

...

...

...

Name of the clinical research facility (CRF):

Address of the CRF:

Tel:                                                    Fax:

Email:

Full name of the principal researcher:

Tel:                                                    Email:

We hereby request the Ministry of Health to approve the clinical research on medical device including the following contents:

- Phase of clinical research:

- Name of medical device

...

...

...

- Type of medical device:

- Name of manufacturer:

- Address of manufacturer:

- Name of owner of medical device:

- Address of owner:

Enclosures:

1.

2.

The CRF and principal researcher hereby declare that there is no conflict of interests between parties in the research, and they will comply with the research protocol approved by the Ministry of Health, comply with the good clinical practice – GCP and regulations on clinical researches on medical device.

...

...

...

Principal researcher(signature)

Head of the CRF(signature and seal)

 

Template No. 02

Ministry of Health

Explanation of clinical research protocol on medical device

I. General information on clinical research on medical device

1. Name of the research

 

...

...

...

2. Code (written by supervisory authority)

3. Duration:

(form …(month)…./20..  to …(month)….20..)

4. Managerial level:

State *                      Ministry/Province *

5.

Funding

Total:

 Sources of funding ……….

...

...

...

6

Phase of clinical research:

 

7

Principal researcher:

Full name:

Academic title/ academic qualification:

Scientific title:

Tel:                        (CQ)/                               (NR)                                  Fax:

...

...

...

Email:

Office address:

Home address:

 

8

Research organization

Name of organization:

Tel:                                                    Fax:                              Email:

Address:

...

...

...

9

Copyright holder (the organization that holds the copyright of the proposed device and uses the clinical research result to put the device into mass production, operation, or initiate the next phase of research):

Name of organization

Tel:                                                    Fax:                              Email:

Office address:

 

Full name(for individuals):

Academic title/ academic qualification:

Scientific title:

...

...

...

Mobile phone:

Email:

Office address:

Home address:

 

II. Contents of clinical research on medical device

(provide description of each phase according to requirements of the Instruction on clinical research on medical devices)

10

Goals:

...

...

...

 

 

11

Current status of the clinical research on medical device in Vietnam and abroad.

 

□ Current status                                     * New research                       * Next phase

 

□ Detailed description of medical device (manufacturing technology, technical features, product quality, process of use, operation, assessment methods, possible risks and hazards and measures to ensure safety for researchers and participant)

 

...

...

...

 

Abroad:

 

 

In Vietnam:

 

 

□ List of relative clinical researches on medical devices published within the last 10 years.

 

...

...

...

12

Approach, method and technique(clearly justify approach - research design, selection of sample, sample size, criteria for selecting research subject, research method, technique to be used - compare with other similar solutions, research criteria, technical means and equipment to determine research criteria; state the novelty, originality and creativity of this research design and research method)

12.1 Research site:

 

12.2 Research duration:

 

12.3 Research method:describe the type of evaluation, (randomized, blinded, open), evaluation design (parallel groups, matched pairs), blinding technique (double-blind, single-blind), method and process of randomization.

 

12.4 Research subject:describe the research subject (standards of selection and elimination of potential subjects), standard operating procedures (SOPs) for the selection of the subject: method, standard and point of time of appointing the subject to the research group.

...

...

...

12.5 Sample size:the required number of subjects to reach the goal of evaluation, based on the statistics.

 

12.6 Medical device to be evaluated:Briefly describe the medical device to be evaluated, including name of the medical device, category, applied technology, main specifications, indications and applications. The specific information on batches of medical devices used in the research: name, manufacturer, batch number, date of manufacture, expiry date, proof of quality inspection.  Packing, labelling, storage, preservation, transport, instructions for use and notes during the process of use of the medical device. Analyses and assessments of the risk level/ benefits from use of the medical device, latent side effects of the medical device and suitable safety solutions for patients and health workforce.

 

12.7 Regimen of proposed device:

 

12.8 Polytherapy:any other treatments that could have been defined or allowed to be used at the same time.

 

12.9 Research data and ways to collect research data.

...

...

...

12.10 Adverse event recording and reporting:The method for recording and reporting cases of adverse reactions (ARs) or adverse events (AEs) and compliance-related clauses.

 

12.11 Adverse event processing

 

12.12 Standards of elimination of the subject in the process of research:Standards of elimination for the research subject and instructions for termination of whole or part of the research.

 

12.13 Blinding technique and protection of identification of the research subject:procedures for maintaining subject identification lists, clinical records, lists of randomly selected subjects and/or case report forms (CRFs). These records must allow separation of patients and participants, as well as data inspection and acquisition.

 

  12.14 Code breaking:information regarding the establishment of trial codes, information regarding where the list is stored, who is allowed to perform code break, when and how the code break is allowed in the event of a medical emergency.

...

...

...

12.15 Method of data processing and outcome evaluation:describe methods used to evaluate outcomes (including statistical methods) and reports on patients or participants dropping out of the evaluation.

 

12.16 Method of information provision for subjects:Information provided for subjects for evaluation, including which information they will be provided, and when and how their consent forms are collected.

 

12.17 Training for research groups:training for researchers involved in the clinical research (including: research leader, sub-leader, coordinator, researchers, pharmacists, nurses, technicians) including: Basics of the research, information on how to conduct evaluation, standard operating procedures (SOPs) for management and use of the proposed medical devices.

12.18  Issues concerning ethics:considerations and ethics-related measures concerning the evaluation. (including: methods, procedures for selection of research subjects, Informed Consent Form (ICF)/Information letter and consent form, Research Ethics position statement).

12.19 Post-evaluation health care:health care provided after evaluation and treatment methods used after evaluation.

12.20 Plans

 

...

...

...

- Supervision of the principal researcher and the research group

- Supervision by donors

- Supervision and inspection by supervisory authorities, Research ethics committee (REC).

 

12.22. SOPs of the research

 

13

Research contents(list and describe contents to be researched, concentrate on new and contents suitable to solve stated issues and attain mentioned research goals, including planned joint operations to transfer research results to users)

 

...

...

...

- Task 1:

- Task 2:

- ........

13.2. Content 2:

- Task 1:

- Task 2:

- ........

 

..........

...

...

...

 

14

International cooperation

Name of partner

Cooperation contents

 

 

 

 

...

...

...

 

15

Progress

No.

Main contents and tasks(Important milestones)

Target products

Starting time – Ending time

Authority/ Participants

1

...

...

...

3

4

5

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

16

Expected results

□ Diagram

□ Data table

□ Analysis reports, conclusions of effect, suitability and safety of the medical device

□ Forecasts for the next phase of the clinical research

□ Instructions for use of the medical device.

□ Process

□ Other products

...

...

...

Product requirements

No.

Product name

Scientific name

Remark

(1)

(2)

(3)

(4)

...

...

...

 

 

 

2

 

 

 

3

 

...

...

...

 

18

Method for transfer of research results

 

19

Impacts of research results(in addition to the impacts mentioned in section 18 above)

□ Training and refresher training for Science and technology officers

 

□ As for related scientific fields:

...

...

...

□ As for society and economy:

 

 

IV. Organization/individual participating in the clinical research on the medical device

20

Activities of cooperating organizations.

(specify all organizations cooperating in conducting the research and their tasks)

No.

Name of the organization

...

...

...

Activities/ contributions to the research

1

 

 

 

 

2

 

 

...

...

...

 

3

 

 

 

 

....

 

 

...

...

...

21

Connection with manufacture and life

(Specify manufacturer or users of research results participating in the process and specify their tasks)

 

 

 

22

Research personnel

(Specify up to 10 persons making major contributions of all presiding and participating organizations)

...

...

...

Full name

Workplace

Percentage (%) of working period for the research

a

Principal researcher

 

 

B

 

...

...

...

 

2

 

....

Officials participating in the research

 

 

V. Funding and sources of funding

(see the attached Appendix for detail explanations)

...

...

...

23

 Sources of funding for different expenditures

No.

Source of funding

Total

Including

Services

Materials, energy

Device, machinery

...

...

...

Others

1

2

3

4

5

6

7

8

...

...

...

 

1

 

2

Total funding

Where:

Science budget

 

Other capital sources (specify)

...

...

...

- Equity

- Others (mobilized capitals, etc.)

 

 

 

 

 

 

 

...

...

...

Head of the research organization(full name, signature and seal)

Principal researcher(full name and signature)

 

.......    …(location)………(date) ....................Director Generalof the Administration of Science, Technology and Training

 

estimated costs of the clinical research

Unit: million VND

No.

Items of expenditures

...

...

...

Capital source

Funding

Percentage (%)

Science budget

Donation

Others

1.

Services

 

...

...

...

 

 

 

2.

Materials and energy

 

 

 

 

...

...

...

3.

Special-use machinery/ equipment

 

 

 

 

 

4.

Construction, minor repair

...

...

...

 

 

 

 

5.

Others

 

 

 

...

...

...

 

Total

 

 

 

 

 

 

Explanations of expenditures(million VND)

...

...

...

No.

Description

Total funding

Capital source

Science budget

Donation

Others

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

Total

 

 

 

 

Clause 2. Materials and energy

No.

Content

...

...

...

Quantity

Unit price

Amount

Capital source

Science budget

Donation

Others

2.1

Materials

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

2.2

Tools, spare parts

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

2.3

...

...

...

 

 

 

 

 

 

 

 

- Coke

...

...

...

 

 

 

 

 

 

 

- Electricity

kW/h

...

...

...

 

 

 

 

 

 

- Gasoline

 

 

...

...

...

 

 

 

 

 

- Others

 

 

 

...

...

...

 

 

 

2.4

Water

m3

 

 

 

...

...

...

 

 

2.5

Books, documents and data

 

 

 

 

 

...

...

...

 

Total

 

 

 

 

Clause 3. Special-use machinery/ equipment

No.

Content

...

...

...

Quantity

Unit price

Amount

Capital source

Science budget

Donation

Others

3.1

Technological devices

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

3.2

Evaluation and measurement instruments

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

3.3

Equipment depreciation

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

3.4

Equipment rental

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

3.5

Transport and installation

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

Clause 4. Construction, minor repair

No.

Content

Funding

Capital source

...

...

...

Donation

Others

4.1

Expenditures of construction of .....square meters of space for workshops, laboratories

 

 

 

 

4.2

...

...

...

 

 

 

 

4.3

Expenditures of installation of electricity/water system

 

 

 

...

...

...

4.4

Others

 

 

 

 

 

 

 

...

...

...

 

 

 

Total

 

 

 

 

Clause 5. Other expenditures

...

...

...

Content

Funding

Capital source

Science budget

Donation

Others

5.1

Business trip expenses

 

...

...

...

 

 

 

 

 

 

 

 

 

...

...

...

 

 

 

 

5.2

Management expenses

 

 

 

...

...

...

 

 

 

 

 

 

5.3

Costs of evaluation, inspection and acceptance

 

...

...

...

 

 

 

- Appraisal costs

 

 

 

 

 

...

...

...

 

 

 

 

 

- Supervision costs

 

 

 

...

...

...

 

- Costs of intermediate inspection and acceptance

 

 

 

 

 

- Costs of internal inspection and acceptance

 

...

...

...

 

 

 

- Costs of official inspection and acceptance

 

 

 

 

5.4

...

...

...

 

 

 

 

 

- Training

 

 

 

...

...

...

 

- Conferences

 

 

 

 

 

- Printing of documents and office stationery

 

...

...

...

 

 

 

- Translation of documents

 

 

 

 

 

...

...

...

 

 

 

 

5.5

Allowances for researchers

 

 

 

...

...

...

 

Total

 

 

 

 

 

Informed Consent Form (ICF)

Name of the research:

...

...

...

Name of the organization or individual having the proposed medical device:

Subject code:…………………………..

This document is fully notified to subjects involved in the research. Do not skip any page or part of this document. Contents of this document must be verbally explained to subjects involved in the research.

1. Description of issues relating to the research, research purpose, scheduled duration and method (specify subjects to be evaluated)

2. Standards of selection of subjects

3. Standards of removal of subjects from the research

4. Who will be the assessor of personal information and medical information to select you to participate in this research? 

5. Number of subjects involved in the research

6. Description of risks or adverse conditions

...

...

...

8. Payments you will receive during the research

9. Substitution therapies or treatments

10. Storage method of keeping personal documents secure

11. Inspectors and supervisors of your application, etc.

12. Compensation or caring and treatment in case a health issue occurs

13. Persons that you can contact when you have any question relating to the research

Your participation in the research is voluntary and you are entitled to refuse to participate or stop participating at any point of time during the research but your medical care still be ensured. 

 

 

...

...

...

 

Informed consent form (ICF)

(For subjects involved in the research)

I, ……………………………………………………………………………….

hereby declare that

– I have read all the provided information about the research ………………………..  in the ICF, edition….., dated ….., with ….. pages).

– I have been given clear explanations for the research and procedures for registering voluntary participation in the research by the researchers.

– I have had opportunities for addressing questions about the research and I get a great deal of satisfaction from the given answers.

– I have had a time and opportunity to consider participating in this research.

...

...

...

– I have understood that I can withdraw from the research at any point of time for any reason.

– I agree that doctors who are providing me with treatment (if any) will be notified of this participation in the research.

 I agree/disagree to participate in this research, tick to the appropriate box:

Agree:

 

 

Disagree:

 

 

...

...

...

………………………………………….....................

Day/month/year

…………................…

If required,

 

* Signature of the witness

………………………………………….....................

Day/month/year

…………................…

...

...

...

………………………………………….....................

 

Signature of the person who provides research information and takes the ICF

………………………………………….....................

Day/month/year

…………................…

Name of the person who provides research information and takes the ICF

………………………………………….....................

 

...

...

...

INFORMED CONSENT FORM (ICF)

(For legal guardians of participants in the research)

I (write full name in block capitals): …………………………………………………………….

am (specify the relation with the participant in the research) ………………… and am a legal guardian of (write full name of the participant in the research in block capitals) …………………………

hereby declare that

– ( I have read all the provided information about the research ………………………..  in the ICF, edition….., dated ….., with ….. pages).

– I have been given clear explanations for the research and procedures for registering voluntary participation in the research by the researchers.

– I have had opportunities for addressing questions about the research and I get a great deal of satisfaction from the given answers.

– I have had a time and opportunity to consider permitting my ……….. who is …………….. to participate in this research.

...

...

...

– I have understood that my ……………. can withdraw from the research at any point of time for any reason.

– I agree that doctors who are providing my ……….. with treatment (if any) will be notified of this participation in the research.

I agree/disagree to let my ……… participate in this research, tick to the appropriate box:

Agree:

 

 

Disagree:

 

 

...

...

...

………………………………………….....................

Day/month/year

…………................…

If required,

 

* Signature of the witness

………………………………………….....................

Day/month/year

…………................…

...

...

...

………………………………………….....................

 

Signature of the person who provides research information and takes the ICF

………………………………………….....................

Day/month/year

…………................…

Full name of the person who provides research information and takes the ICF

………………………………………….....................

 

...

...

...

Template No. 03

Ministry of HealthNational Biomedical Research ethics committee (REC)-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.           /CN-HDDD

Hanoi, day    month    year 20…

 

CERTIFICATE

of REC’s approval

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on the establishment of the REC for the tenure of …..;

...

...

...

Pursuant to Document No. ......./BB-HDDDQG dated …………. of the REC;

The REC hereby approves the clinical research protocol in terms of ethics and science:

1. Name of the research: ………………………………………..

2. The principal researcher: ………………

3. The CRF: …………………………

4. Research site: ………………………………………………

5. Research subjects: ……………………………………………………………………………………..

6. Estimated number of subjects: ……………………………………

7. Duration of the research: ……………………………………..

...

...

...

Changes during the research must be considered and approved by REC, unless such these changes are necessary to eliminate direct risks to the subjects.

The principal researcher and CRF must report adverse events and extremely adverse events to the REC in accordance with applicable regulations.

 

 

Chairperson of the REC

 

Template No. 04

MINISTRY OF HEALTH OF VIETNAM-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

...

...

...

Hanoi, day    month    year 20….….

 

DECISION

On approval for clinical research protocol

MINISTER OF HEALTH

Pursuant to Decree No. …………/ND-CP dated…………………. of the Government on functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices;

Pursuant to Circular No. .............../TT-BYT dated ………………, 2021 of the Ministry of Health on ……………………………….;

Pursuant to Circular No. 04/2020/TT-BYT dated March 05, 2020 of the Minister of Health on establishment, functions, tasks and powers of REC;

...

...

...

HEREBY DECIDES:

Article 1.Approval for clinical research protocol on medical devices

1. Name of the research: ………………………………………..

2. Phase of the research: ………………………………………..

3. The principal researcher: ………………

4. The CRF: …………………………

5. The sponsor:……………………………………………..

6. Name of the manufacturer: ……………………………….

7. Research site: ………………………………………………

...

...

...

9. Estimated number of subjects: ……………………………………

10. Duration of the research: ……………………………………..

11. Estimated cost: …………………………..

12. Source of funding: ………………………………

Article 2.Head ofCRF must ensure adherence to Good Clinical Practice (GCP) throughout the research. The Chairperson of the REC shall monitor and supervise the compliance with the approved clinical research protocol, assess the recognition, handling, report and monitoring of adverse events occurring during the research. The principal researcher and research group shall conduct the research in conformity with the approved clinical research protocol and applicable regulations.  The sponsors shall manage, support and supervise the research to have its quality ensured and the research data authenticated.

Article 3.TheHead of the CRF, the Chairperson of the REC at the grassroots level, the principal researcher and the sponsor shall comply with all regulations of the State on scientific and technological activities, research service agreements and financial expenditures; comply with GCP guidelines and applicable relevant regulations, thereby ensuring the perfect safety for subjects involved in the research.

Article 4.This Decision comes into force from the day on which it is signed.

Article 5.Directors of the Administration of Science, Technology and Training, the Chairperson of the REC, the Head of the CRF and Heads of relevant units are responsible for implementation of this Decision.

 

...

...

...

Position of the approverSignature (full name, title)Confirmed by seal or signature 

 

Template No. 05

FACILITY’S NAME-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.     /……..Re. application for approval for changes in the clinical research protocol

Hanoi, day   month    year 20….

 

To: The Ministry of Health (Administration of Science, Technology and Training)

...

...

...

Address of the CRF:

Tel:                                                    Fax:

Email:

Full name of the principal researcher:

Tel:                                                    Email:

We have been permitted to conduct the clinical research on medical devices [name of the research] by the Ministry of Health at Decision No.      /QD-BYT dated ……………………

We hereby request approval for the following changes:

No

Changes

...

...

...

List of documents concerning the changes

1.

 

 

 

2.

 

 

 

...

...

...

 

 

 

Enclosures:

....

After studying Decree No. 98/2021/ND-CP dated November 08, 2021 on management of medical devices, including regulations on clinical research on medical devices and relevant regulations, we hereby declare that we will fully comply with legal documents, professional regulations and code of ethics in research. We request the Ministry of health (via the Administration of Science, Technology and Training) to consider and approve the above-mentioned changes of the facility.

 

Principal researcher(signature)

Head of the CRF(signature and seal)

...

...

...

Template No. 06

MINISTRY OF HEALTHRESEARCH ETHICS COMMITTEE (REC)-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.           /CN-HDDD

Hanoi, day    month    year 20…

 

CERTIFICATE

of REC’s approval for changes in the research

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on establishment of REC for the tenure of …..;

...

...

...

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on approval for the clinical research protocol “Name of the research";

At the request of "CRF's name" at Official Dispatch No. ……………. dated …………….. on application for amendments to the research,

The REC hereby approves use of the following documents instead of their previous editions:

No.

Name of document

Edition/date

1

Explanation of the protocol

- Vietnamese edition . ……………, published on day… month.... year....

...

...

...

Clinical research protocol

- Revised Vietnamese edition . ……………, published on day… month.... year....

- English edition . ……………, published on day… month.... year.... (if any)

3

………………..

 

Approval date: (dd/mm/yyyy)….…...….

Changes in the conduct of the research requiring consideration and approval of the REC, except if changes are necessary to eliminate direct risks to the subjects.

The principal researcher must report adverse events and extremely adverse events to the REC in accordance with applicable regulations.

...

...

...

 

CHAIRPERSON OF THE REC

 

Template No. 07

MINISTRY OF HEALTH OF VIETNAM-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.        /QD-BYT

Hanoi, day    month    year 20….….

 

...

...

...

On approval for revised clinical research protocol

MINISTER OF HEALTH

Pursuant to Decree No. ……./ND-CP  dated ……………. of the Government on functions, tasks, powers and organizational structure of the Ministry of Health of Vietnam;

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices

Pursuant to Circular No. .............../TT-BYT dated ………………, 2021 of the Ministry of Health on ……………………………….;.

Pursuant to Circular No. 04/2020/TT-BYT dated March 05, 2020 of the Minister of Health on establishment, functions, tasks and powers of REC;

At the request of the Director of the Administration of Science, Technology and Training affiliated to the Ministry of Health.

HEREBY DECIDES:

Article 1.Approval for the revised clinical research protocol:

...

...

...

The principal researcher: ………………

The CRF: …………………………

Research site: ................................................

Revised contents in the Explanation of the clinical research protocol, edition …………………, published on ......... [date]............, include:

1. ......................................

2. ......................................

3. ......................................

Article 2.Head of CRF must ensure compliance to GCP throughout the research. The Chairperson of the REC shall monitor and supervise the compliance with the approved clinical research protocol, assess the recognition, handling, report and monitoring of adverse events occurring during the research. The principal researcher and research group shall conduct the research according to the approved clinical research protocol and applicable regulations.  The sponsors shall manage, support and supervise the research to have its quality ensured and the research data authenticated.

Article 3.The Head of the CRF, the Chairperson of the REC at the grassroots level, the principal researcher and the sponsor shall comply with all regulations of the State on scientific and technological activities, research service agreements and financial expenditures; comply with GCP guidelines and applicable relevant regulations, thereby ensuring the perfect safety for subjects involved in the research.

...

...

...

Article 5.Directors of the Administration of Science, Technology and Training, the Chairperson of the REC, the Head of the CRF and Heads of relevant units are responsible for implementation of this Decision.

 

 

POSITION OF APPROVERSignature (full name, title)Confirmed by seal or signature 

 

Template No. 08

FACILITY’S NAME-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.      /…..Re. Application for approval for results of clinical research on the medical device

...

...

...

 

To: The Ministry of Health (Administration of Science, Technology and Training)

The CRF: …………………………

The cooperating facility in the research:

The principal researcher:

We hereby request the Ministry of Health (via the Administration of Science, Technology and Training) to consider and approve results of the clinical research on the medical device:

- Name of the research:

- Code of the research:

- Research duration:

...

...

...

- Name of the medical device:

-  Category:

- Type of the medical device:

- Name of the manufacturer:

- Address of the manufacturer:

- Name of the owner of the medical device:

- Address of the owner:

Enclosures:

......

...

...

...

Principal researchersignature

Head of the CRFsignature and seal

 

Template No. 09

The cover page

MINISTRY OF HEALTH

 

 

 

...

...

...

 

 

 

Name of the research:

 

 

 

The principal researcher:

Research organization: 

...

...

...

 

 

20

 

The title page

 

MINISTRY OF HEALTH

 

 

...

...

...

Clinical research report

 

Name of the research:

 

 

            The principal researcher:

            Research organization

            Supervisory authority: the Ministry of Health

            Code of the reseach (if any): …………………………..

...

...

...

                        Total funding for conducting the research: VND…………… million

                        Where: Science budget: VND …………. million

                        Others (if any): VND …………….. million

 

 

20

 

Page 3

 

...

...

...

 

 

1. Name of the research:

2. The principal researcher:

3. Research organization:

4. Supervisory authority: the Ministry of Health 

5. The research secretary:

6. List of main performers:

-

...

...

...

-

7. Research sites

            (a) Research site 1

                        - Site:

                        - The principal researcher:

            (b) Research site 2

                        - Site:

                        - The principal researcher:

8. Research duration: from month …. year …. to month…. year …..

...

...

...

Page 4

 

Abbreviations

 

Table of contents

Part A. Abstract

Part B. Detailed contents of the report

1. Introduction:

1.1. Brief introduction of relevant researches in Vietnam and abroad

...

...

...

1.3 Assumptions of the research

1.4 Research objectives

2. Overall research design:

2.1. Relevant researches in foreign countries

2.2. Relevant researches in Vietnam

3. Research subjects and research methods:

3.1. Research design

3.2. Selection of samples, sample sizes and research subjects.

3.3. Research methods

...

...

...

3.3.2. Methods for determination of criteria of the research.

3.3.3. Specific research tools.

3.4. Method of data processing.

4. Results of the research:

4.1 Brief description of the proposed device, including function, model of the device, technology, characteristics and method of use.

4.2 Analysis of the selected documents and data, advantages and disadvantages.

4.3 Joint assessment of risks and danger and appropriate safety measures for patients and health workforce.

4.4 Assessments of cultural, geographical, and demographic factors (for example: age, nationality, gender, etc.).

4.5 Equivalent methods of use of the device on the same safety standards and considerations of ethics

...

...

...

5. Discussion:

6. Conclusion and recommendation:

7. References:

8. Appendix (if any):….

 

Template No. 10

MINISTRY OF HEALTHRESEARCH ETHICS COMMITTEE (REC)-------

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.           /CN-HDDD

...

...

...

 

CERTIFICATE

Of results of clinical research on medical device

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on establishment of REC for the tenure of …..;

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on promulgation of the regulation on organization and operation of the REC for the tenure of …..;

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices

Pursuant to Decision No. ............/QD-BYT dated …………. of the Minister of Health on approval for the clinical research protocol “Name of the research";

At the request of "CRF's name" at Official Dispatch No. ……………. dated …………….. on application for amendments to the research,

Pursuant to Document No. …/BB-BNCDD dated …………. of the REC on assessment of results of the clinical research on the medical device;

...

...

...

1. Name of the research:

2. Phase of the research:

3. The principal researcher:

4. The CRF:

5. Name of the organization or individual having the proposed medical device:

6. Reseach site:

7. Research subjects:

8. Number of research subjects:

9. Research duration:

...

...

...

11. Manufacturer:

12. Instructions for use, regimen of the proposed product: according to the research protocol approved at Decision No. …/QD-BYT dated …………… of the Ministry of Health.

13. Date of acceptance meeting of the REC:

Approval date: (dd/mm/yyyy)…...….

 

 

CHAIRPERSON OF THE REC

 

Template No. 11

...

...

...

SOCIALIST REPUBLIC OF VIETNAMIndependence - Freedom – Happiness---------------

No.        /QD-BYT

Hanoi, day    month    year 20….….

 

DECISION

On approval for results of clinical research on medical devices

MINISTER OF HEALTH

Pursuant to Decree No. 75/2017/ND-CP dated June 20, 2017 of the Government on function, tasks, powers and organizational structures of the Ministry of Health of Vietnam;

Pursuant to Decree No. 98/2021/ND-CP dated November 08, 2021 of the Government on management of medical devices;

...

...

...

Pursuant to the Certificate of results of clinical research on medical device No. ……… dated …………. Of the REC;

At the request of the Director of the Administration of Science, Technology and Training affiliated to the Ministry of Health.

HEREBY DECIDES:

Article 1.Approval for results of clinical research on medical devices:

1. Name of the research: ………………………………………..

2. Phase of the research: ………………………………………..

3. The principal researcher: ………………

4. The CRF: …………………………

4. Name of the medical device:…………………………………

...

...

...

6. Type of the medical device: ………………………………………….

7. Name of the owner of the medical device:………………

8. The owner’s address: …………………………………………………………………………..

9. The sponsor: ……………………………….

10. Name of the manufacturer: …………………………………………………………………

11. Address of the manufacturer: ......................................................................................

12. Research site: ................................................

13. Research subjects: ………………………………………..

14. Estimated number of research subjects: ………………………………………..

...

...

...

16. Procedures and instructions for use of the medical device: …………………………..

17. The REC’s conclusion of the acceptance of the results: ……………………

Article 2.This Decision comes into force from the day on which it is signed.

Article 3.Directors of the Administration of Science, Technology and Training, the Chairperson of the REC, the Head of the CRF and Heads of relevant units are responsible for implementation of this Decision.

 

 

POSITION OF THE approverSignature (full name, title)Confirmed by seal or signature 

 

 

...

...

...

 

Từ khóa: 19/2021/TT-BYT Thông tư 19/2021/TT-BYT Thông tư số 19/2021/TT-BYT Thông tư 19/2021/TT-BYT của Bộ Y Tế Thông tư số 19/2021/TT-BYT của Bộ Y Tế Thông tư 19 2021 TT BYT của Bộ Y Tế

Nội dung đang được cập nhật.
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được hướng dẫn () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị hủy bỏ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được bổ sung () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Đình chỉ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị đình chỉ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị đinh chỉ 1 phần () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị quy định hết hiệu lực () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị bãi bỏ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được sửa đổi () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được đính chính () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bị thay thế () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được điều chỉnh () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Được dẫn chiếu () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Văn bản hiện tại

Số hiệu 19/2021/TT-BYT
Loại văn bản Thông tư
Cơ quan Bộ Y Tế
Ngày ban hành 16/11/2021
Người ký Đỗ Xuân Tuyên
Ngày hiệu lực
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.
Tình trạng
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Hướng dẫn () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Hủy bỏ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bổ sung () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Đình chỉ 1 phần () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Quy định hết hiệu lực () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Bãi bỏ () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Sửa đổi () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Đính chính () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Thay thế () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Điều chỉnh () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Dẫn chiếu () Xem thêm Ẩn bớt

    Xem chi tiết
    Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Tải văn bản gốc
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

Tải văn bản Tiếng Việt
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.

ĐĂNG NHẬP
Quên mật khẩu?
Google Facebook

Bạn chưa có tài khoản? Hãy Đăng ký

Đăng ký tài khoản
Google Facebook

Bạn đã có tài khoản? Hãy Đăng nhập

Tóm tắt

Số hiệu 19/2021/TT-BYT
Loại văn bản Thông tư
Cơ quan Bộ Y Tế
Ngày ban hành 16/11/2021
Người ký Đỗ Xuân Tuyên
Ngày hiệu lực
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.
Tình trạng
Đã biết
Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.
Thêm ghi chú

Tin liên quan

  • Thuê trọ nhưng không đăng ký tạm trú, sinh viên bị xử phạt như thế nào?
  • Thu nhập từ lãi gửi tiền ở các tổ chức tín dụng có phải nộp thuế thu nhập cá nhân hay không?
  • Hành vi lấn chiếm vỉa hè sẽ bị xử phạt như thế nào?
  • Đi xem phim và quay lén lại đăng lên mạng xã hội có bị xử phạt không

Bản án liên quan

  • Thuê trọ nhưng không đăng ký tạm trú, sinh viên bị xử phạt như thế nào?
  • Thu nhập từ lãi gửi tiền ở các tổ chức tín dụng có phải nộp thuế thu nhập cá nhân hay không?
  • Hành vi lấn chiếm vỉa hè sẽ bị xử phạt như thế nào?
  • Đi xem phim và quay lén lại đăng lên mạng xã hội có bị xử phạt không

Mục lục

CÔNG TY CỔ PHẦN PHÁT TRIỂN VÀ ỨNG DỤNG CÔNG NGHỆ SỐ VINASECO

Trụ sở: Số 19 ngõ 174 Trần Vỹ, Mai Dịch, Cầu Giấy, Hà Nội - Hotline: 088 66 55 213 - Email: [email protected]

ĐKKD: 0109181523 do Phòng Đăng ký kinh doanh - Sở Kế hoạch và Đầu tư TP. Hà Nội cấp ngày 14/05/2020

Sơ đồ WebSite

Thông báo

Để xem thông tin này, vui lòng đăng nhập tài khoản gói nâng cao. Nếu chưa có tài khoản vui lòng đăng ký.